±±¾©Ê¯ÓÍ»¯¹¤Ñ§Ôº2026ÄêÑо¿ÉúÕÐÉú½ÓÊÕµ÷¼Á¹«¸æ
²é¿´: 486  |  »Ø¸´: 2
±¾Ìû²úÉú 1 ¸ö ·­ÒëEPI £¬µã»÷ÕâÀï½øÐв鿴

xiaowanzi9

гæ (ÕýʽдÊÖ)

[ÇóÖú] ÇóÖúÒ»¶Î·­Òë¡£Á¿´ó

Finally, we investigated direct effects
of fumaric acid esters on the inhibitor of Nrf2, Keap1 in vitro.
Mass spectroscopy revealed a covalent modification at the cysteine
residue 151 of the Keap1 protein after monomethylfumarate treatment (Fig. 5G). The matched Keap1 peptides (peptide score
47) from a SpectrumMill database search covered 95% of the rat
Keap1 protein sequence. After stimulation with monomethylfumarate,
a 130 Da mass increase of the Keap1 tryptic peptide
CVLHVMNGAVMYQIDSVVR was observed. The mass increase
of 130 Da is consistent with a Michael addition of a free cysteine
sulphydryl group across the monomethylfumarate double bond.
The MS/MS spectrum of the peptide confirms this modification
at cysteine 151 (Fig. 5G). The assignment of 130 Da to the monomethylfumarate
modification is consistent (within 0.14 mmu)
with a chemical formula of C5H6O4 (130.02661 exp. and
130.02647 cal.). The ion intensity ratio of the modified and unmodified
peptides are 69 and 31%, respectively. The monomethylfumarate
induced 130 Da modification was also
observed¨C¨Cto a much lower extent¨C¨Cin other cysteine-containing
Keap1 peptides (Table 2).

» ²ÂÄãϲ»¶

ÈçÔ¸
ÒÑÔÄ   »Ø¸´´ËÂ¥   ¹Ø×¢TA ¸øTA·¢ÏûÏ¢ ËÍTAºì»¨ TAµÄ»ØÌû

genhunter

ÖÁ×ðľ³æ (ÖøÃûдÊÖ)

¡¾´ð°¸¡¿Ó¦Öú»ØÌû

¡ï ¡ï ¡ï ¡ï ¡ï ¡ï ¡ï ¡ï ¡ï ¡ï ¡ï ¡ï ¡ï ¡ï ¡ï ¡ï ¡ï ¡ï ¡ï ¡ï
xiaowanzi9: ½ð±Ò+20 2015-05-25 16:26:12
×îºó£¬ÎÒÃÇÑо¿ÁËÌåÍâ·´¶¡Ï©¶þËáÖ¬¶ÔNrf2ÒÖÖ¹ÎïKeap1µÄÖ±½Ó×÷ÓÃ(»òЧӦ). ÖÊÆ×ÏÔʾKeap1λÓÚ151µÄ°ëë×°±ËáÉϵÄÛÏ»ùÔÚ·´¶¡Ï©¶þËáµ¥¼×Ö¬´¦Àíºó±»¹²¼ÛÐÞÊÎÁË(ͼ 5G)¡£Í¨¹ý´ÓSpectrum MillÊý¾Ý¿âÖи²¸Ç95%´óÊóKeap1µ°°×˳Ðò¼ìË÷ÕÒµ½Á˼¸¸ö¶àëÄÆ¬¶Î(¶àëÄͬԴֵΪ47)¡£Í¨¹ýÓ÷´¶¡Ï©¶þËáµ¥¼×֬ģÄ⣬Keap1ÒÈø½µ½â¶àëÄÆ¬¶ÎCVLHVMNGAVMYQIDSVVR·Ö×ÓÁ¿»áÔö¼Ó130 Da. ·Ö×ÓÁ¿Ôö¼Ó130 DaÊÇÓÉÓÚÒ»¸öÓÎÀëÛÏ»ùÓë·´¶¡Ï©¶þËáµ¥¼×֬˫¼üͨ¹ýÂõ¿Ë¶û¼Ó³ÉºóÐγɵġ£.  MS/MSͼÆ×È·ÈÏÐÞÊÎλÓÚλÓÚ151µÄ°ëë×°±ËáÉÏ. ·Ö×ÓÁ¿Ôö¼Ó130 DaÍÆËã³ö·´¶¡Ï©¶þËáµ¥¼×Ö¬»ùÍÅÓëÆä»¯Ñ§Ê½C5H6O4ÏàÎǺÏ(¾«È·µ½0.14mmu, ʵ²â130.02661 £¬ÀíÂÛÖµ 130.02647)¡£¾­ÐÞÊκÍδ¾­ÐÞÊεĶàëÄÀë×Ó·åÖµ±ÈÀý·Ö±ðÊÇ69ºÍ31%¡£·´¶¡Ï©¶þËáµ¥¼×Ö¬Ò²µ¼ÖÂͬÑù130 DaÐÞÊÎÔÚÆäËûº¬°ëë×°±ËáµÄKeap1¶àëÄÆ¬¶ÎÖÐÒ²¿É¹Û²ìµ½£¬µ«º¬Á¿ÒªµÍºÜ¶à¡£(±í¶þ)
Àë³É¹¦»¹²îÒ»µã
2Â¥2015-05-25 15:50:31
ÒÑÔÄ   »Ø¸´´ËÂ¥   ¹Ø×¢TA ¸øTA·¢ÏûÏ¢ ËÍTAºì»¨ TAµÄ»ØÌû

Î人һÐÄÒ»Òë

¾èÖú¹ó±ö (ÖøÃûдÊÖ)


¡¾´ð°¸¡¿Ó¦Öú»ØÌû

É̼ÒÒѾ­Ö÷¶¯ÉùÃ÷´Ë»ØÌû¿ÉÄܺ¬ÓÐÐû´«ÄÚÈÝ
¡ï ¡ï ¡ï ¡ï ¡ï ¡ï ¡ï ¡ï ¡ï ¡ï ¡ï ¡ï ¡ï ¡ï ¡ï ¡ï ¡ï ¡ï ¡ï ¡ï ¡ï ¡ï ¡ï ¡ï ¡ï ¡ï ¡ï ¡ï ¡ï ¡ï
xiaowanzi9: ½ð±Ò+30, ·­ÒëEPI+1 2015-05-25 16:26:09
Finally, we investigated direct effects of fumaric acid esters on theinhibitor of Nrf2, Keap1 in vitro.
×îºó£¬ÎÒÃÇÑо¿ÁË ·´¶¡Ï©¶þËáËáõ¥¶ÔKeap1ÌåÍ⣬Nrf2µÄÒÖÖÆ¼ÁµÄÖ±½Ó×÷Óà 


Mass spectroscopy revealed a covalent modification at the cysteineresidue 151 of the Keap1 protein after monomethylfumarate treatment (Fig. 5G). The matched Keap1 peptides (peptide score 47) from a Spectrum Mill database search covered 95% of the rat Keap1 protein sequence.
ÖÊÆ×·ÖÎö±íÃ÷£¬ ÔËÓø»ÂíËáµ¥¼×õ¥½øÐд¦Àíºó£¬»áÐγÉÒ»ÖÖ£¬¶ÔKeap1µ°°×Öʵİëë×°±Ëá²Ð»ù151µÄ¹²¼ÛÐÞÊΣ¨Èçͼ5G£©¡£Í¨¹ý¹âÆ×Êý¾Ý¿âËÑË÷»ñµÃµÄÓë֮ƥÅäµÄKeap1¶àëÄ£¨ëÄ·ÖΪ47£©£¬ ¸²¸ÇÁË95%µÄÀÏÊóKeap1µ°°×ÖÊÐòÁС£


After stimulation with monomethylfumarate,a 130 Da mass increase of the Keap1 tryptic peptide CVLHVMNGAVMYQIDSVVR was observed. The mass increase of 130 Da is consistent with a Michael addition of a free cysteine sulphydryl group across the monomethylfumarate double bond.
ÔËÓø»ÂíËáµ¥¼×õ¥½øÐд̼¤ºó£¬¿ÉÒԹ۲쵽£¬Keap1Òȵ°°×øëÄ£¬»á²úÉú130 Da¼¶µÄÖÊÁ¿Ôö¼Ó¡£¸Ã130DaµÄÖÊÁ¿Ôö¼Ó£¬Óë×ÔÓɰëë×°±ËáÛÏ»ù¼¯ÍÅÔÓ½»¸»ÂíËáµ¥¼×õ¥Ë«¼ü£¬µÄÂõ¿Ë¶û¼Ó³É·´Ó¦Ò»Ö¡£


The MS/MS spectrum of the peptide confirms this modification at cysteine 151 (Fig. 5G). The assignment of 130 Da to the monomethylfumarate modification is consistent (within 0.14 mmu) with a chemical formula of
C5H6O4 (130.02661 exp. and 130.02647 cal.). The ion intensity ratio of the modified and unmodified peptides are 69 and 31%, respectively.
Ëõ°±ËáµÄ´®ÁªÊ½ÖÊÆ×·¨£¬È·¶¨Á˰ëë×°±Ëá151£¨Èçͼ5G£© ÐÞÊΡ£130 Da·ÖÅäµ½¸»ÂíËáµ¥¼×õ¥ÐÞÊΣ¬Ó루ÔÚ0.14 mmuÄڵģ©C5H6O4µÄ»¯Ñ§Ê½ £¨130.02661 exp. and 130.02647 cal.£©Ò»Ö¡£ÐÞÊÎ/δÐÞÊεÄëĵÄÏà¶ÔÀë×ÓÇ¿¶È±È·Ö±ðΪ69% ºÍ 31%¡£


The monomethylfumarate induced 130 Da modification was also observed¨C¨Cto a much lower extent¨C¨Cin other cysteine-containing Keap1 peptides (Table 2).
ͬʱ£¬Ò²¿ÉÒԹ۲쵽¸»ÂíËáµ¥¼×õ¥Óз¨µÄ130 DaµÄÐÞÊΡ£ÔÚº¬ÆäËü°ëë×°±ËáµÄKeap1¶àëÄÖУ¬ÆäÐÞÊγ̶ȸüµÍ¡££¨Èç±í¶þËùʾ£©
3Â¥2015-05-25 15:54:36
ÒÑÔÄ   »Ø¸´´ËÂ¥   ¹Ø×¢TA ¸øTA·¢ÏûÏ¢ ËÍTAºì»¨ TAµÄ»ØÌû
Ïà¹Ø°æ¿éÌø×ª ÎÒÒª¶©ÔÄÂ¥Ö÷ xiaowanzi9 µÄÖ÷Ìâ¸üÐÂ
×î¾ßÈËÆøÈÈÌûÍÆ¼ö [²é¿´È«²¿] ×÷Õß »Ø/¿´ ×îºó·¢±í
[¿¼ÑÐ] 266Çóµ÷¼Á +7 ѧԱ97LZgn 2026-04-03 7/350 2026-04-04 07:45 by anny19840123
[¿¼ÑÐ] 343Çóµ÷¼Á +8 °®î¿°í 2026-03-29 8/400 2026-04-03 22:19 by –¹Æ?
[¿¼ÑÐ] 311Çóµ÷¼Á +11 Ó¸ҵÄСÎâ 2026-04-02 11/550 2026-04-03 21:46 by qlm5820
[¿¼ÑÐ] 292Çóµ÷¼Á +21 ÊÇåû×ÓÒ²ÊÇÑÐ×Ó 2026-03-30 22/1100 2026-04-03 21:44 by qlm5820
[¿¼ÑÐ] µ÷¼Á +5 asdasdassda 2026-04-03 6/300 2026-04-03 20:27 by °¶ÉϵÄÒ»ÌõÓã
[¿¼ÑÐ] 070300Ò»Ö¾Ô¸211£¬312·ÖÇóµ÷¼ÁԺУ +16 С»ÆÑ¼±¦ 2026-03-30 16/800 2026-04-03 19:53 by lijunpoly
[¿¼ÑÐ] 336Çóµ÷¼Á +8 kiyy 2026-04-01 8/400 2026-04-03 19:41 by lijunpoly
[¿¼ÑÐ] 266Çóµ÷¼Á +18 ÑôÑôÍÛÈû 2026-04-01 18/900 2026-04-03 18:38 by zllcz
[¿¼ÑÐ] Çóµ÷¼Á£¬Ò»Ö¾Ô¸Ö£ÖÝ´óѧ²ÄÁÏÓ뻯¹¤×¨Ë¶£¬Ó¢¶þÊý¶þ342·Ö£¬ÇóÀÏʦÊÕÁô +17 v12abo 2026-04-02 18/900 2026-04-03 16:38 by lijunpoly
[¿¼ÑÐ] 085600£¬²ÄÁÏÓ뻯¹¤321·ÖÇóµ÷¼Á +12 ´ó²öС×Ó 2026-03-28 12/600 2026-04-03 14:16 by °ÙÁéͯ888
[¿¼ÑÐ] 085600ר˶²ÄÁÏÓ뻯¹¤348·ÖÇóµ÷¼Á +10 ÉÏѧÀ²£¡ 2026-04-01 11/550 2026-04-03 14:13 by °ÙÁéͯ888
[¿¼ÑÐ] 085501Ò»Ö¾Ô¸Ì칤´ó£¬»úеר˶Çóµ÷¼Á£¬¿ç²ÄÁÏ +3 33ÉÏ 2026-04-03 3/150 2026-04-03 14:08 by 1753564080
[¿¼ÑÐ] 298Çóµ÷¼Á +5 ÖÖÊ¥´Í 2026-03-28 5/250 2026-04-03 12:26 by xingguangj
[»ù½ðÉêÇë] ÇëÎʹ²Í¬Í¨Ñ¶ºÍ¹²Í¬Ò»×÷µÄÈϿɶÈÎÊÌâ 10+4 psa1234 2026-04-01 10/500 2026-04-03 11:08 by Kittylucky
[¿¼ÑÐ] һ־Ըɽ¶«´óѧ»¯Ñ§Ó뻯¹¤Ñ§Ôº²ÄÁÏÓ뻯¹¤×¨Ë¶£¬360·ÖÇóµ÷¼Á +4 ²»Ô¸Í¸Â¶ÐÕÃûµÄË 2026-04-02 4/200 2026-04-03 09:29 by ÒÅÍüÏûʧµÄž™
[¿¼ÑÐ] 266Çóµ÷¼Á +4 ѧԱ97LZgn 2026-04-02 4/200 2026-04-02 13:03 by yulian1987
[¿¼ÑÐ] Ò»Ö¾Ô¸346ÉϺ£´óѧÉúÎïѧ +3 ÉϺ£´óѧ346µ÷¼Á 2026-04-01 3/150 2026-04-02 08:36 by w³æ³æ123
[¿¼ÑÐ] ²ÄÁÏר˶306Ó¢Ò»Êý¶þ +7 z1z2z3879 2026-03-31 7/350 2026-04-01 14:50 by ZXlzxl0425
[¿¼ÑÐ] 313Çóµ÷¼Á +6 Âô¸ö¹Ø×Ó°É 2026-03-31 6/300 2026-03-31 10:58 by Jaylen.
[¿¼ÑÐ] µ÷¼Á¿¼ÑÐ +3 Íõ½ÜÒ» 2026-03-29 3/150 2026-03-29 08:09 by fmesaito
ÐÅÏ¢Ìáʾ
ÇëÌî´¦ÀíÒâ¼û